Previous close | 2.4200 |
Open | 2.3800 |
Bid | 2.3600 x 0 |
Ask | 2.6400 x 0 |
Day's range | 2.3800 - 2.5000 |
52-week range | 1.6340 - 2.8550 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BOSTON, April 18, 2024--PureTech Health: Notice of Results
BOSTON, April 16, 2024--PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
BOSTON, April 11, 2024--PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers